Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 07-Oct-24 7:55 AM View:  | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 03-Oct-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 50% 28.51K to 42.88K | |
| 07-Oct-24 7:55 AM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 03-Oct-24 | Planned Option Sale | 14,375 | $54.63 | $785,306.00 | (34%) 42.88K to 28.51K | |
| 30-Sep-24 5:01 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 26-Sep-24 | Option Exercise | 25,000 | $15.29 | $382,250.00 | 23% 111.09K to 136.09K | |
| 30-Sep-24 5:01 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 26-Sep-24 | Planned Option Sale | 25,000 | $51.11 | $1,277,750.00 | (18%) 136.09K to 111.09K | |
| 28-Aug-24 4:31 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 26-Aug-24 | Private Sale (Planned) | 3,000 | $53.19 | $159,570.00 | (4%) 72.61K to 69.61K | |
| 14-Aug-24 4:30 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 12-Aug-24 | Private Sale (Planned) | 3,000 | $47.68 | $143,040.00 | (4%) 75.61K to 72.61K | |
| 26-Jul-24 4:24 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jul-24 | Option Exercise | 19,056 | $9.28 | $176,840.00 | 17% 111.09K to 130.15K | |
| 26-Jul-24 4:24 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jul-24 | Planned Option Sale | 19,056 | $53.88 | $1,026,740.00 | (15%) 130.15K to 111.09K | |
| 26-Jul-24 4:38 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jul-24 | Private Sale (Planned) | 3,000 | $53.43 | $160,290.00 | (4%) 78.61K to 75.61K | |
| 17-Jul-24 5:35 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Option Exercise | 26,073 | $22.59 | $589,116.00 | 50% 52.58K to 78.65K | |
| 17-Jul-24 5:35 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Sale (Planned) | 927 | $55.00 | $50,985.00 | (2%) 52.58K to 51.65K | |
| 17-Jul-24 5:14 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Planned Option Sale | 25,000 | $55.00 | $1,375,000.00 | (18%) 136.09K to 111.09K | |
| 17-Jul-24 5:14 PM View: | Wilson Marc CFO | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Option Exercise | 25,000 | $20.02 | $500,500.00 | 23% 111.09K to 136.09K | |
| 17-Jul-24 5:35 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 15-Jul-24 | Planned Option Sale | 26,073 | $55.00 | $1,434,020.00 | (33%) 78.65K to 52.58K | |
| 12-Jul-24 4:30 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 10-Jul-24 | Private Sale (Planned) | 3,000 | $48.55 | $145,650.00 | (4%) 81.61K to 78.61K | |
| 09-Jul-24 6:04 PM View: | Hassard James Chief Commercial Officer | Crinetics Pharmaceuticals, ... (CRNX) | 05-Jul-24 | Planned Option Sale | 15,000 | $44.08 | $661,200.00 | (34%) 44.26K to 29.26K | |
| 09-Jul-24 6:04 PM View: | Hassard James Chief Commercial Officer | Crinetics Pharmaceuticals, ... (CRNX) | 05-Jul-24 | Option Exercise | 15,000 | $19.73 | $295,950.00 | 51% 29.26K to 44.26K | |
| 05-Jul-24 4:30 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jul-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 50% 28.51K to 42.88K | |
| 05-Jul-24 4:30 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 03-Jul-24 | Planned Option Sale | 14,375 | $44.87 | $645,006.00 | (34%) 42.88K to 28.51K | |
| 28-Jun-24 5:31 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 26-Jun-24 | Private Sale (Planned) | 956 | $44.38 | $42,427.30 | (2%) 53.54K to 52.58K | |
| 26-Jun-24 4:32 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 25-Jun-24 | Private Sale (Planned) | 3,000 | $45.37 | $136,110.00 | (4%) 83.64K to 80.64K | |
| 25-Jun-24 5:03 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 24-Jun-24 | Option Sale | 9,500 | $45.73 | $434,435.00 | (25%) 37.29K to 27.79K | |
| 25-Jun-24 5:03 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 24-Jun-24 | Option Exercise | 9,500 | $16.89 | $160,455.00 | 34% 27.79K to 37.29K | |
| 24-Jun-24 5:08 PM View: | Hassard James Chief Commercial Officer | Crinetics Pharmaceuticals, ... (CRNX) | 21-Jun-24 | Planned Option Sale | 15,000 | $44.66 | $669,900.00 | (34%) 44.26K to 29.26K | |
| 24-Jun-24 5:08 PM View: | Hassard James Chief Commercial Officer | Crinetics Pharmaceuticals, ... (CRNX) | 21-Jun-24 | Option Exercise | 15,000 | $19.73 | $295,950.00 | 51% 29.26K to 44.26K | |
| 11-Jun-24 4:35 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 10-Jun-24 | Private Sale (Planned) | 3,000 | $43.86 | $131,580.00 | (3%) 86.64K to 83.64K | |
| 11-Jun-24 4:21 PM View: | Deardorf Caren Director | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 57% 6.0K to 9.4K | |
| 11-Jun-24 4:20 PM View: | Nichols Weston Director | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 57% 6.0K to 9.4K | |
| 11-Jun-24 4:20 PM View: | Okey Stephanie Director | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 57% 6.0K to 9.4K | |
| 11-Jun-24 4:19 PM View: | Bedrosian Camille L Director | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 57% 6.0K to 9.4K | |
| 11-Jun-24 4:21 PM View: | Vivaldi Coelho Rogerio Director | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 31% 11.0K to 14.4K | |
| 11-Jun-24 4:19 PM View: | Fust Matthew K Director | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 18% 18.54K to 21.94K | |
| 11-Jun-24 4:18 PM View: | Wierenga Wendall D Director | Crinetics Pharmaceuticals, ... (CRNX) | 07-Jun-24 | Grant | 3,400 | -- | -- | 3% 105.85K to 109.25K | |
| 30-May-24 4:28 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 28-May-24 | Private Sale (Planned) | 3,000 | $47.49 | $142,470.00 | (3%) 89.64K to 86.64K | |
| 14-May-24 6:29 PM View: | Betz Stephen F. Chief Scientific Officer | Crinetics Pharmaceuticals, ... (CRNX) | 10-May-24 | Private Sale (Planned) | 3,000 | $49.43 | $148,290.00 | (3%) 92.64K to 89.64K | |
| 10-May-24 4:57 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 08-May-24 | Planned Option Sale | 107,448 | $49.40 | $5,307,930.00 | (8%) 1.27M to 1.16M | |
| 10-May-24 4:57 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 08-May-24 | Option Exercise | 107,448 | $9.28 | $997,117.00 | 9% 1.16M to 1.27M | |
| 22-Apr-24 5:23 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 18-Apr-24 | Gift | 350 | -- | -- | (< 1%) 1.16M to 1.16M | |
| 17-Apr-24 4:36 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Planned Option Sale | 14,375 | $44.47 | $639,256.00 | (34%) 42.16K to 27.79K | |
| 17-Apr-24 4:30 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Option Exercise | 20,000 | $1.91 | $38,200.00 | 2% 1.14M to 1.16M | |
| 17-Apr-24 4:36 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 15-Apr-24 | Option Exercise | 14,375 | $16.89 | $242,794.00 | 52% 27.79K to 42.16K | |
| 08-Apr-24 5:09 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 04-Apr-24 | Option Exercise | 40,951 | $9.28 | $380,025.00 | 4% 1.14M to 1.18M | |
| 08-Apr-24 5:09 PM View: | Struthers Richard Scott President & CEO Director | Crinetics Pharmaceuticals, ... (CRNX) | 04-Apr-24 | Planned Option Sale | 40,951 | $49.17 | $2,013,560.00 | (3%) 1.18M to 1.14M | |
| 02-Apr-24 4:35 PM View: | Okey Stephanie Director | Crinetics Pharmaceuticals, ... (CRNX) | 28-Mar-24 | Option Sale | 17,500 | $46.38 | $811,650.00 | (74%) 23.5K to 6.0K | |
| 02-Apr-24 4:35 PM View: | Okey Stephanie Director | Crinetics Pharmaceuticals, ... (CRNX) | 28-Mar-24 | Option Exercise | 17,500 | $18.29 | $320,075.00 | 292% 6.0K to 23.5K | |
| 26-Mar-24 4:30 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Option Exercise | 30,000 | $23.98 | $719,400.00 | 55% 54.94K to 84.94K | 4% |
| 26-Mar-24 4:30 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Private Option Sale | 30,000 | $44.31 | $1,329,160.00 | (35%) 84.94K to 54.94K | |
| 26-Mar-24 4:30 PM View: | Knight Jeff E. Chief Operating Officer | Crinetics Pharmaceuticals, ... (CRNX) | 22-Mar-24 | Sale | 2,359 | $44.31 | $104,516.00 | (4%) 54.94K to 52.58K | |
| 22-Mar-24 4:52 PM View: | Pizzuti Dana Chief Med and Dev Officer | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Sale | 714 | $44.06 | $31,456.10 | (3%) 28.5K to 27.79K | |
| 22-Mar-24 4:31 PM View: | Fust Matthew K Director | Crinetics Pharmaceuticals, ... (CRNX) | 20-Mar-24 | Planned Option Sale | 60,000 | $44.14 | $2,648,150.00 | (76%) 78.54K to 18.54K |
